Search Results - "Brown, Milton E."

Refine Results
  1. 1

    MCUb Induction Protects the Heart From Postischemic Remodeling by Huo, Jiuzhou, Lu, Shan, Kwong, Jennifer Q., Bround, Michael J., Grimes, Kelly M., Sargent, Michelle A., Brown, Milton E., Davis, Michael E., Bers, Donald M., Molkentin, Jeffery D.

    Published in Circulation research (17-07-2020)
    “…Mitochondrial Ca loading augments oxidative metabolism to match functional demands during times of increased work or injury. However, mitochondrial Ca overload…”
    Get full text
    Journal Article
  2. 2

    Cellular encapsulation enhances cardiac repair by Levit, Rebecca D, Landázuri, Natalia, Phelps, Edward A, Brown, Milton E, García, Andres J, Davis, Michael E, Joseph, Giji, Long, Robert, Safley, Susan A, Suever, Jonathan D, Lyle, Alicia N, Weber, Collin J, Taylor, W Robert

    Published in Journal of the American Heart Association (10-10-2013)
    “…Stem cells for cardiac repair have shown promise in preclinical trials, but lower than expected retention, viability, and efficacy. Encapsulation is one…”
    Get full text
    Journal Article
  3. 3

    Using computational methods to design patient-specific electrospun cardiac patches for pediatric heart failure by Streeter, Benjamin W., Brown, Milton E., Shakya, Preety, Park, Hyun-Ji, Qiu, Jichuan, Xia, Younan, Davis, Michael E.

    Published in Biomaterials (01-04-2022)
    “…Autologous cardiac cell therapy is a promising treatment for combating the right ventricular heart failure (RVHF) that can occur in patients with congenital…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Identification of Therapeutic Covariant MicroRNA Clusters in Hypoxia-Treated Cardiac Progenitor Cell Exosomes Using Systems Biology by Gray, Warren D, French, Kristin M, Ghosh-Choudhary, Shohini, Maxwell, Joshua T, Brown, Milton E, Platt, Manu O, Searles, Charles D, Davis, Michael E

    Published in Circulation research (16-01-2015)
    “…RATIONALE:Myocardial infarction is a leading cause of death in developed nations, and there remains a need for cardiac therapeutic systems that mitigate tissue…”
    Get full text
    Journal Article
  7. 7

    Over-expression of catalase in myeloid cells confers acute protection following myocardial infarction by Cabigas, E Bernadette, Somasuntharam, Inthirai, Brown, Milton E, Che, Pao Lin, Pendergrass, Karl D, Chiang, Bryce, Taylor, W Robert, Davis, Michael E

    “…Cardiovascular disease is the leading cause of death in the United States and new treatment options are greatly needed. Oxidative stress is increased following…”
    Get full text
    Journal Article
  8. 8

    Customized Loading of microRNA-126 to Small Extracellular Vesicle-Derived Vehicles Improves Cardiac Function after Myocardial Infarction by Bheri, Sruti, Brown, Milton E., Park, Hyun-Ji, Brazhkina, Olga, Takaesu, Felipe, Davis, Michael E.

    Published in ACS nano (24-10-2023)
    “…Small extracellular vesicles (sEVs) are promising for cell-based cardiac repair after myocardial infarction. These sEVs encapsulate potent cargo, including…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A Bioprinted Cardiac Patch Composed of Cardiac‐Specific Extracellular Matrix and Progenitor Cells for Heart Repair by Bejleri, Donald, Streeter, Benjamin W., Nachlas, Aline L. Y., Brown, Milton E., Gaetani, Roberto, Christman, Karen L., Davis, Michael E.

    Published in Advanced healthcare materials (01-12-2018)
    “…Congenital heart defects are present in 8 of 1000 newborns and palliative surgical therapy has increased survival. Despite improved outcomes, many children…”
    Get full text
    Journal Article
  11. 11

    Aggregation of Child Cardiac Progenitor Cells Into Spheres Activates Notch Signaling and Improves Treatment of Right Ventricular Heart Failure by Trac, David, Maxwell, Joshua T, Brown, Milton E, Xu, Chunhui, Davis, Michael E

    Published in Circulation research (15-02-2019)
    “…RATIONALE:Congenital heart disease can lead to life-threatening right ventricular (RV) heart failure. Results from clinical trials support expanding cardiac…”
    Get full text
    Journal Article
  12. 12

    Encapsulation of Pediatric Cardiac-Derived C-Kit + Cells in Cardiac Extracellular Matrix Hydrogel for Echocardiography-Directed Intramyocardial Injection in Rodents by Shakya, Preety, Brown, Milton E, Davis, Michael E

    “…Pediatric cardiac-derived c-kit cell therapies represent an innovative approach for cardiac tissue repair that have demonstrated promising improvements in…”
    Get more information
    Journal Article
  13. 13

    High-throughput screening identifies microRNAs that target Nox2 and improve function after acute myocardial infarction by Yang, Junyu, Brown, Milton E, Zhang, Hanshuo, Martinez, Mario, Zhao, Zhihua, Bhutani, Srishti, Yin, Shenyi, Trac, David, Xi, Jianzhong Jeff, Davis, Michael E

    “…Myocardial infarction (MI) is the most common cause of heart failure. Excessive production of ROS plays a key role in the pathogenesis of cardiac remodeling…”
    Get more information
    Journal Article
  14. 14

    Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction by Somasuntharam, Inthirai, Yehl, Kevin, Carroll, Sheridan L, Maxwell, Joshua T, Martinez, Mario D, Che, Pao-Lin, Brown, Milton E, Salaita, Khalid, Davis, Michael E

    Published in Biomaterials (01-03-2016)
    “…Abstract In this study, we used deoxyribozyme (DNAzyme) functionalized gold nanoparticles (AuNPs) to catalytically silence tumor necrosis factor-α (TNF-α)…”
    Get full text
    Journal Article
  15. 15

    Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction by Somasuntharam, Inthirai, Boopathy, Archana V, Khan, Raffay S, Martinez, Mario D, Brown, Milton E, Murthy, Niren, Davis, Michael E

    Published in Biomaterials (01-10-2013)
    “…Abstract Myocardial infarction (MI) is the most common cause of heart failure (HF), the leading cause of death in the developed world. Oxidative stress due to…”
    Get full text
    Journal Article
  16. 16

    Imaging the Activation of Low-Boiling-Point Phase-Change Contrast Agents in the Presence of Tissue Motion Using Ultrafast Inter-frame Activation Ultrasound Imaging by Jing, Bowen, Brown, Milton E., Davis, Michael E., Lindsey, Brooks D.

    Published in Ultrasound in medicine & biology (01-06-2020)
    “…Nanoscale phase-change contrast agents (PCCAs) have been found to have great potential in non-invasive extravascular imaging and therapeutic delivery. However,…”
    Get full text
    Journal Article
  17. 17

    Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction by Liu, Jie, Gu, Catherine, Cabigas, E. Bernadette, Pendergrass, Karl D, Brown, Milton E, Luo, Ying, Davis, Michael E

    Published in Biomaterials (01-05-2013)
    “…Abstract Cardiovascular disease (CVD) is the leading cause of death throughout the world and much pathology is associated with upregulation of inflammatory…”
    Get full text
    Journal Article
  18. 18

    Intramyocardial Delivery of Notch Ligand-Containing Hydrogels Improves Cardiac Function and Angiogenesis Following Infarction by Boopathy, Archana V, Martinez, Mario D, Smith, Amanda Walker, Brown, Milton E, García, Andrés J, Davis, Michael E

    Published in Tissue engineering. Part A (01-09-2015)
    “…Myocardial infarction (MI) is the leading cause of death worldwide. Notch1 signaling plays a critical role in cardiac development, in survival, cardiogenic…”
    Get more information
    Journal Article
  19. 19
  20. 20

    The modulation of cardiac progenitor cell function by hydrogel-dependent Notch1 activation by Boopathy, Archana V, Che, Pao Lin, Somasuntharam, Inthirai, Fiore, Vincent F, Cabigas, E. Bernadette, Ban, Kiwon, Brown, Milton E, Narui, Yoshie, Barker, Thomas H, Yoon, Young-Sup, Salaita, Khalid, García, Andrés J, Davis, Michael E

    Published in Biomaterials (01-09-2014)
    “…Abstract Myocardial infarction is the leading cause of death worldwide and phase I clinical trials utilizing cardiac progenitor cells (CPCs) have shown…”
    Get full text
    Journal Article